Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019
Authors:
- Yong-Jian GengYGYong-Jian Geng
- Zhi-Yao WeiZWZhi-Yao Wei
- Hai-Yan QianHQHai-Yan Qian
- Ji HuangJHJi Huang
- Robert LodatoRLRobert Lodato
- Richard J. CastriottaRCRichard J. Castriotta
- 1 July 2020
- journal article
- review article
- Published by Elsevier in Cardiovascular Pathology
- Vol. 47, 107228
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 69 references indexed in Scilit:
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune ResponseJournal of Virology, 2011
- Upregulation of the Chemokine (C-C Motif) Ligand 2 via a Severe Acute Respiratory Syndrome Coronavirus Spike-ACE2 Signaling PathwayJournal of Virology, 2010
- SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARSEuropean Journal of Clinical Investigation, 2009
- Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entryProceedings of the National Academy of Sciences, 2008
- SARS: Systematic Review of Treatment EffectsPLOS Medicine, 2006
- Cardiovascular complications of severe acute respiratory syndromePostgraduate Medical Journal, 2006
- Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2Circulation, 2005
- Angiotensin-Converting Enzyme Is Involved in Outside-In Signaling in Endothelial CellsCirculation Research, 2004
- A Human Homolog of Angiotensin-converting EnzymeJournal of Biological Chemistry, 2000
- Myocardial oxygen consumption: The quest for its determinants and some clinical falloutJACC, 2000